XtalPi and Pfizer Expand Partnership to Advance AI-Driven Drug Discovery and Materials Simulation

• XtalPi has expanded its collaboration with Pfizer to develop an advanced AI-powered molecular modeling platform, aiming to improve the speed and accuracy of small-molecule drug discovery by combining physics-based methods with scalable AI tools
• Under the expansion, XtalPi and Pfizer will develop predictive models tailored to Pfizer’s chemical space, enhancing small-molecule drug discovery.
• XtalPi will provide its XFEP platform to support Pfizer’s research with improved accuracy, speed, and usability across various drug development scenarios. A 2024 joint paper published by XtalPi and Pfizer introduced the first-generation XtalPi Force Field (XFF)

Ref: Prnewswire | Image: XtalPi and Pfizer| Press Release

Related News:- Mabwell Announces Novel Drug Technology License Agreement with Qilu Pharmaceutical for Albipagrastim alfa for Injection

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com